Document is current
Any future updates will be listed below
-
Authors
Weiss, Pamela F. https://orcid.org/0000-0002-9724-0443
Utidjian, Levon
Maltenfort, Mitchell
Razzaghi, Hanieh
Brandon, Timothy G.
Muir, Cassandra
Sears, Cora
Oberle, Edward J.
Cooper, Jennifer
Baszis, Kevin
Toth, Mary B.
Morgan, Esi M.
Forrest, Christopher B.
-
Funding
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (CER-2020C1-19212)
- License Information
-
More Information
Article History
Received: 20 August 2025
Accepted: 24 December 2025
First Online: 31 January 2026
Declarations
:
: The study was approved by the institutional review board (IRB) at the Children’s Hospital of Philadelphia (CHOP) (IRB protocol number 17-014012) with a waiver of consent. The study also used the PEDSnet Master Reliance Agreement (protocol number 16-012878) process whereby participating institutions ceded IRB review to CHOP.
: Not applicable.
: PFW – Royalties/licenses: Up-to-date (<$10K to author); Consulting fees: Site investigator for Pfizer and Abbvie Clinical Trials (Payment to institution), Advisory Board member: Lily, Novartis (all <$10K to author), and Consulting fees: Pfizer (payment to institution); Speaking payment or honoraria: 2022 Rheum Now Speaker (<$5K to author) and Spondyloarthritis Research and Treatment Network – honoraria for educational materials (<$5k to author). The other authors have no conflict of interest to declare.
